AI assistant
Sending…
Arcadia Biosciences, Inc. — Director's Dealing 2016
Aug 22, 2016
35424_dirs_2016-08-22_7f6f1852-b2f1-4bb7-a80a-6cfadab7b39b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-08-18
Reporting Person: Shupp Darby E (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-08-18 | Stock Option (right to buy) | $2.14 | A | 24149 | Acquired | 2026-08-17 | Common Stock (24149) | Direct |
Footnotes
F1: The option will become 100% vested and exercisable on the earlier to occur of (i) August 18, 2017 or (ii) the date of the Issuer's next Annual Meeting of Stockholders.
More from Arcadia Biosciences, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Feb 6
Regulatory Filings
2026
Jan 28
Regulatory Filings
2026
Jan 14
M&A Activity
2025
Dec 29
Regulatory Filings
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 23
Annual Report
2025
Nov 19